PACS GroupPACS +0.36%19 PS Ratio is 1.33 as of Jul. 03, 2026, which is 36% above its 10-year median of 0.98. GuruFocus rates PACS with a GF Score™ of 19/100. The stock has 6 warning signs investors should review. Among 659 Healthcare Providers & Services companies, PACS Group ranks better than 55.24% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PACS Group's share price is $44.48.
PACS Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $33.51. Hence, PACS Group's PS Ratio for today is 1.33.
Warning Sign:
PACS Group Inc stock PS Ratio (=1.33) is close to 1-year high of 1.33.
The historical rank and industry rank for PACS Group's PS Ratio or its related term are showing as below:
PACS'
s PS Ratio Range Over the Past 10 Years
Min: 0.33 Med: 0.98 Max: 1.88
Current: 1.33
During the past 5 years, PACS Group's highest PS Ratio was 1.88. The lowest was 0.33. And the median was 0.98.
PACS's PS Ratio is ranked better than 55.24% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs PACS: 1.33
During the past 12 months, the average Revenue per Share Growth Rate of PACS Group was 19.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 27.90% per year.
During the past 5 years, PACS Group's highest 3-Year average Revenue per Share Growth Rate was 52.40% per year. The lowest was 27.90% per year. And the median was 40.15% per year.
Back to Basics: PS Ratio
PACS Group (NYSE:PACS) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
PACS Group PS Ratio Related Terms
PACS Group PS Ratio Historical Data
* Premium members only.
The historical data trend for PACS Group's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PACS Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PACS Group PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PACS Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where PACS Group's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
PACS Group's Share Price of today is $44.48. PACS Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $33.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PACS Group (PACS) has a PS Ratio of 1.33 as of Jul. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PACS Group and its competitors. This is 36% above median its historical median of 0.98. Over the past decade, PACS Group's PS Ratio has ranged from 0.33 to 1.88. According to the industry distribution chart, PACS Group ranks #295 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 44.8%.
Is PACS Group's PS Ratio too high?
PACS Group's current PS Ratio of 1.33 is 36% above median its 10-year median of 0.98. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 1.88. The Healthcare Providers & Services industry median PS Ratio is 1.52. PACS Group's value of 1.33 is 12.5% below this industry median. Based on the distribution chart, PACS Group ranks #295 out of 659 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PACS Group has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does PACS Group's PS Ratio compare to CHE and UHS?
According to the Healthcare Providers & Services industry distribution chart, PACS Group ranks #295 out of 659 companies for PS Ratio. This puts PACS Group in the upper half of its industry. The industry median PS Ratio is 1.52. PACS Group's value of 1.33 is 12.5% below this benchmark. Historically, PACS Group's own PS Ratio has ranged from 0.33 to 1.88 over the past decade. While the company's 10-year median is 0.98 vs. the industry median of 1.52, PACS Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PACS Group's current PS Ratio of 1.33 is 12.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PACS Group and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PACS Group's current PS Ratio is 1.33, which is 36% above median its own 10-year median of 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PACS Group stock overvalued right now?
PACS Group (PACS) has a current PS Ratio of 1.33. The current PS Ratio is 1.33, which is 36% above median its 10-year median of 0.98 and 12.5% below the Healthcare Providers & Services industry median of 1.52. PACS Group's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For PACS Group (PACS), the current PS Ratio is 1.33 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
19GF Score
Get the complete analysis for PACS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PACS has been successfully added to your 
